Order Article Reprints

Amann V, Kissmann A-K, Krämer M, Krebs I, Perez-Erviti JA, Otero-Gonzalez AJ, Morales-Vicente F, Rodríguez A, Ständker L, Weil T, et al. Increased Activities against Biofilms of the Pathogenic Yeast Candida albicans of Optimized Pom-1 Derivatives. Pharmaceutics. 2022; 14(2):318. https://doi.org/10.3390/pharmaceutics14020318

Amann, Valerie, Ann-Kathrin Kissmann, Markus Krämer, Imke Krebs, Julio A. Perez-Erviti, Anselmo J. Otero-Gonzalez, Fidel Morales-Vicente, Armando Rodríguez, Ludger Ständker, Tanja Weil, and et al. 2022. "Increased Activities against Biofilms of the Pathogenic Yeast Candida albicans of Optimized Pom-1 Derivatives" Pharmaceutics 14, no. 2: 318. https://doi.org/10.3390/pharmaceutics14020318

Amann, V., Kissmann, A.-K., Krämer, M., Krebs, I., Perez-Erviti, J. A., Otero-Gonzalez, A. J., Morales-Vicente, F., Rodríguez, A., Ständker, L., Weil, T., & Rosenau, F. (2022). Increased Activities against Biofilms of the Pathogenic Yeast Candida albicans of Optimized Pom-1 Derivatives. Pharmaceutics, 14(2), 318. https://doi.org/10.3390/pharmaceutics14020318